Haemostasis and metastasis: anticoagulants therapeutic potential in ovarian cancer

QR Code

Haemostasis and metastasis: anticoagulants therapeutic potential in ovarian cancer

Aim: to perform a comparative analysis of epithelial ovarian cancer (ОС) recurrence rate in patients with/without long-term anticoagulant therapy (АСТ) as a part of secondary prevention of thrombotic complications.Materials and Methods. A prospective interventional non-randomized comparative study w...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Vorobev, V. O. Bitsadze, J. Kh. Khizroeva, A. G. Solopova, D. M. Mamchich, E. D. Mun, D. V. Blinov, J.-C. Gris, I. Elalamy, G. Gerotziafas, P. Van Dreden, A. D. Makatsariya
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2025-07-01
Series:	Акушерство, гинекология и репродукция
Subjects:	anticoagulant therapy аст ovarian cancer oc relapse metastasis venous thromboembolism direct oral anticoagulants thrombin fibrin matrix thrombosis tumor invasion antitumor effect
Online Access:	https://www.gynecology.su/jour/article/view/2493
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New Oral Anticoagulants: General Features and Review of Pivotal Clinical Trials
by: Sung-Won Jang
Published: (2016-12-01)

Coagulation status in patients with pulmonary embolism receiving long-term anticoagulant therapy
by: E. A. Shmidt, et al.
Published: (2022-01-01)

Long-term anticoagulant therapy in the aspect of secondary prevention of recurrent pulmonary embolism
by: E. A. Shmidt, et al.
Published: (2024-06-01)

Anticoagulants: dose control methods and inhibitors
by: V. O. Bitsadze, et al.
Published: (2022-05-01)

Left ventricular thrombus as a rare complication of pulmonary tuberculosis
by: Amit Kumar, et al.
Published: (2025-04-01)

Recurrent thrombosis in malignant neoplasms: clinical significance of long-term anticoagulant prophylaxis
by: A. V. Vorobеv, et al.
Published: (2025-05-01)

DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01)

Inherited thrombophilia and venous thromboembolism: testing rules in clinical practice
by: I. V. Zotova, et al.
Published: (2020-09-01)

Problematic points of anticoagulant therapy for atrial fibrillation in certain Russian regions in 2016- 2019: results of a retrospective big data analysis
by: M. A. Druzhilov, et al.
Published: (2024-10-01)

Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015-11-01)

HEART RHYTM DISORDERS AND THROMBOSIS. ANTICOAGULANT THERAPY OF CARDIAC ARRHYTHMIAS IN PREGNANCY
by: A. D. Makatsariya, et al.
Published: (2016-06-01)

Efficacy and Safety of Oral Anticoagulants in the Treatment of COVID-19
by: O. G. Ni, et al.
Published: (2021-07-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

Guidance for Endoscopic Procedures in Patients Taking Novel Oral Anticoagulants
by: Kyoung Oh Kim
Published: (2016-12-01)

Anticoagulation in Patients with Liver Cirrhosis (Literature Review)
by: E. S. Eniseeva
Published: (2019-05-01)

ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES
by: Z. M. Safiullina, et al.
Published: (2015-09-01)

Treatment and Secondary Prevention of Venous Thromboembolism in Real Clinical Practice Based on Health Care Professional Survey
by: K. V. Lobastov, et al.
Published: (2021-07-01)

FEATURES OF PROPHYLAXIS OF POSTOPERATIVE VENOUS THROMBOEMBOLISM IN ONCOLOGIC PATIENTS
by: I. I. Katelnitskyy, et al.
Published: (2014-12-01)

Patient with cardioembolic stroke: clinical characteristics and typical features
by: O. I. Efimova, et al.
Published: (2020-06-01)

Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
by: D. V. Pevzner, et al.
Published: (2023-06-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)

Venous Thromboembolism Therapy with Edoxaban in Daily Care Patients: Results from the DRESDEN NOAC REGISTRY
by: Luise Tittl, et al.
Published: (2025-01-01)

Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation
by: S. G. Kanorskii
Published: (2016-09-01)

COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY
by: L. N. Uddin, et al.
Published: (2018-06-01)

Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
by: O. V. Shatalova
Published: (2015-12-01)

ПРИМЕНЕНИЕ ПЕРОРАЛЬНЫХ АНТИКОАГУЛЯНТОВ ПРИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ И НОВЫЕ ВОЗМОЖНОСТИ
by: Г. И. Сторожаков, et al.
Published: (2013-04-01)

Changes in anticoagulant prescription in a general hospital in 2008-2018
by: E. B. Kleymenova, et al.
Published: (2021-09-01)

OPTIONS FOR USE OF APPROPRIATE ANTICOAGULANT THERAPY IN PATIENTS WITH THERMAL INJURY WITH A HIGH RISK OF THROMBOEMBOLIC COMPLICATIONS DEVELOPMENT ASSOCIATED WITH RECURRENT INTESTINAL BLEEDING
by: V. S. Borisov, et al.
Published: (2016-02-01)

Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation
by: L. N. Uddin, et al.
Published: (2019-07-01)

Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients
by: A. B. Sumarokov, et al.
Published: (2020-03-01)

EFFICACY OF THERAPY WITH INDIRECT ANTICOAGULANTS: ROLE OF THE FOODSTUFF VITAMIN K CONTENTS
by: A. P. Momot, et al.
Published: (2016-01-01)

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
by: D. A. Napalkov, et al.
Published: (2015-09-01)

THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY
by: A. A. Rumyantsev, et al.
Published: (2015-09-01)

Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical Case
by: A. V. Samorodov, et al.
Published: (2020-07-01)

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021-07-01)

Risk of postoperative venous thromboembolic complication development in elderly patients
by: N. M. Krasnova, et al.
Published: (2018-03-01)

Patients with atrial fibrillation and a low risk of thromboembolic events: prescription rate of anticoagulant therapy according to a retrospective analysis
by: M. A. Druzhilov, et al.
Published: (2023-09-01)

Venous thromboembolism prophylaxis practices in hematology/oncology patients admitted to neurological intensive care units
by: Nada Alsuhebany, et al.
Published: (2025-07-01)

Oral Anticoagulants in Chronic Thromboembolic Pulmonary Hypertension: Tradition or Innovation?
by: Domenico Laviola, et al.
Published: (2025-07-01)

Patient's Awareness of Cancer-Associated Thrombosis: A Canadian Nationwide Survey
by: Ana C. Pizzarossa, et al.
Published: (2025-01-01)